Saturday, July 11, 2026

Drug profile · INN

telmisartan + hydrochlorothiazide

telmisartan + hydrochlorothiazide (TELTARTAN HCT 40/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — telmisartan + hydrochlorothiazide

Quick answer

telmisartan + hydrochlorothiazide (TELTARTAN HCT 40/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN telmisartan + hydrochlorothiazide
Brand TELTARTAN HCT 40/12.5

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. DR230297 Phase 3 · Tour Hekla · Acute ischaemic stroke due to basilar artery occlusion.
  2. Metalyse 5 000 units (25 mg) powder for solution for injection Phase 3 · PARItec · Adult patients with a LVOS with large core within 9 hours of
  3. Metalyse 5 000 units (25 mg) powder for solution for injection Phase 3 · Boehringer Ingelheim · Acute Ischemic Stroke

Frequently asked questions

What is telmisartan + hydrochlorothiazide?

telmisartan + hydrochlorothiazide (TELTARTAN HCT 40/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for telmisartan + hydrochlorothiazide?

TELTARTAN HCT 40/12.5 is a marketed brand name for telmisartan + hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.